140 related articles for article (PubMed ID: 9468142)
1. Design of potent selective zinc-mediated serine protease inhibitors.
Katz BA; Clark JM; Finer-Moore JS; Jenkins TE; Johnson CR; Ross MJ; Luong C; Moore WR; Stroud RM
Nature; 1998 Feb; 391(6667):608-12. PubMed ID: 9468142
[TBL] [Abstract][Full Text] [Related]
2. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
Katz BA; Luong C
J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
[TBL] [Abstract][Full Text] [Related]
3. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
4. X-ray crystallographic analyses of complexes between bovine beta-trypsin and Schiff base copper(II) or iron(III) chelates.
Toyota E; Ng KK; Sekizaki H; Itoh K; Tanizawa K; James MN
J Mol Biol; 2001 Jan; 305(3):471-9. PubMed ID: 11152605
[TBL] [Abstract][Full Text] [Related]
5. Design of benzamidine-type inhibitors of factor Xa.
Gabriel B; Stubbs MT; Bergner A; Hauptmann J; Bode W; Stürzebecher J; Moroder L
J Med Chem; 1998 Oct; 41(22):4240-50. PubMed ID: 9784099
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
Miyazaki Y; Kato Y; Manabe T; Shimada H; Mizuno M; Egusa T; Ohkouchi M; Shiromizu I; Matsusue T; Yamamoto I
Bioorg Med Chem Lett; 2006 Jun; 16(11):2986-90. PubMed ID: 16540315
[TBL] [Abstract][Full Text] [Related]
7. Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
Katz BA; Elrod K; Verner E; Mackman RL; Luong C; Shrader WD; Sendzik M; Spencer JR; Sprengeler PA; Kolesnikov A; Tai VW; Hui HC; Breitenbucher JG; Allen D; Janc JW
J Mol Biol; 2003 May; 329(1):93-120. PubMed ID: 12742021
[TBL] [Abstract][Full Text] [Related]
8. Structure of a serpin-protease complex shows inhibition by deformation.
Huntington JA; Read RJ; Carrell RW
Nature; 2000 Oct; 407(6806):923-6. PubMed ID: 11057674
[TBL] [Abstract][Full Text] [Related]
9. Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa.
Mederski WW; Dorsch D; Anzali S; Gleitz J; Cezanne B; Tsaklakidis C
Bioorg Med Chem Lett; 2004 Jul; 14(14):3763-9. PubMed ID: 15203158
[TBL] [Abstract][Full Text] [Related]
10. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR
J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115
[TBL] [Abstract][Full Text] [Related]
11. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
[TBL] [Abstract][Full Text] [Related]
12. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
[TBL] [Abstract][Full Text] [Related]
13. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
14. Oxyanion-mediated inhibition of serine proteases.
Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
Katz BA; Liu B; Barnes M; Springman EB
Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
[TBL] [Abstract][Full Text] [Related]
16. Dimethylthiazolidine carboxylic acid as a rigid p3 unit in inhibitors of serine proteases: application to two targets.
Kawai SH; Aubry N; Duceppe JS; Llinàs-Brunet M; LaPlante SR
Chem Biol Drug Des; 2009 Nov; 74(5):517-22. PubMed ID: 19780760
[TBL] [Abstract][Full Text] [Related]
17. Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.
Tully DC; Vidal A; Chatterjee AK; Williams JA; Roberts MJ; Petrassi HM; Spraggon G; Bursulaya B; Pacoma R; Shipway A; Schumacher AM; Danahay H; Harris JL
Bioorg Med Chem Lett; 2008 Nov; 18(22):5895-9. PubMed ID: 18752942
[TBL] [Abstract][Full Text] [Related]
18. Effects of coordinating metal ions on the mediated inhibition of trypsin by bis(benzimidazoles) and related compounds.
Paul JJ; Kircus SR; Sorrell TN; Ropp PA; Thorp HH
Inorg Chem; 2006 Jun; 45(13):5126-35. PubMed ID: 16780335
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationship of serine protease-protein inhibitor interaction.
Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
[TBL] [Abstract][Full Text] [Related]
20. Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa.
Verner E; Katz BA; Spencer JR; Allen D; Hataye J; Hruzewicz W; Hui HC; Kolesnikov A; Li Y; Luong C; Martelli A; Radika K; Rai R; She M; Shrader W; Sprengeler PA; Trapp S; Wang J; Young WB; Mackman RL
J Med Chem; 2001 Aug; 44(17):2753-71. PubMed ID: 11495587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]